Fennec Pharmaceuticals Inc. beat EPS estimates 67% of the time across 3 reported quarters (2 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.01 | $0.05 | +400.0% | Beat |
| Q12026 FY2026 | $-0.02 | $0.01 | +150.0% | Beat |
| Q42025 FY2025 | $0.03 | $-0.11 | -466.7% | Miss |
Back to FENC overview · FENC holders · FENC KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.